The ratio of radiation dosages required to produce identical change based on a formula comparing other types of radiation with that of gamma or roentgen rays.
Rate of energy dissipation along the path of charged particles. In radiobiology and health physics, exposure is measured in kiloelectron volts per micrometer of tissue (keV/micrometer T).
Positively-charged atomic nuclei that have been stripped of their electrons. These particles have one or more units of electric charge and a mass exceeding that of the Helium-4 nucleus (alpha particle).
Californium. A man-made radioactive actinide with atomic symbol Cf, atomic number 98, and atomic weight 251. Its valence can be +2 or +3. Californium has medical use as a radiation source for radiotherapy.
Neutrons, the energy of which exceeds some arbitrary level, usually around one million electron volts.
Unstable isotopes of cobalt that decay or disintegrate emitting radiation. Co atoms with atomic weights of 54-64, except 59, are radioactive cobalt isotopes.
The use of a heavy ion particle beam for radiotherapy, such as the HEAVY IONS of CARBON.
The relationship between the dose of administered radiation and the response of the organism or tissue to the radiation.
Study of the scientific principles, mechanisms, and effects of the interaction of ionizing radiation with living matter. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
Positively charged particles composed of two protons and two NEUTRONS, i.e. equivalent to HELIUM nuclei, which are emitted during disintegration of heavy ISOTOPES. Alpha rays have very strong ionizing power, but weak penetrability.
Astatine. A radioactive halogen with the atomic symbol At, atomic number 85, and atomic weight 210. Its isotopes range in mass number from 200 to 219 and all have an extremely short half-life. Astatine may be of use in the treatment of hyperthyroidism.
Electrically neutral elementary particles found in all atomic nuclei except light hydrogen; the mass is equal to that of the proton and electron combined and they are unstable when isolated from the nucleus, undergoing beta decay. Slow, thermal, epithermal, and fast neutrons refer to the energy levels with which the neutrons are ejected from heavier nuclei during their decay.
Devices which accelerate electrically charged atomic or subatomic particles, such as electrons, protons or ions, to high velocities so they have high kinetic energy.
Nuclear reaction in which the nucleus of a heavy atom such as uranium or plutonium is split into two approximately equal parts by a neutron, charged particle, or photon.
Penetrating, high-energy electromagnetic radiation emitted from atomic nuclei during NUCLEAR DECAY. The range of wavelengths of emitted radiation is between 0.1 - 100 pm which overlaps the shorter, more energetic hard X-RAYS wavelengths. The distinction between gamma rays and X-rays is based on their radiation source.
The measurement of radiation by photography, as in x-ray film and film badge, by Geiger-Mueller tube, and by SCINTILLATION COUNTING.
Penetrating electromagnetic radiation emitted when the inner orbital electrons of an atom are excited and release radiant energy. X-ray wavelengths range from 1 pm to 10 nm. Hard X-rays are the higher energy, shorter wavelength X-rays. Soft x-rays or Grenz rays are less energetic and longer in wavelength. The short wavelength end of the X-ray spectrum overlaps the GAMMA RAYS wavelength range. The distinction between gamma rays and X-rays is based on their radiation source.
A nonmetallic element with atomic symbol C, atomic number 6, and atomic weight [12.0096; 12.0116]. It may occur as several different allotropes including DIAMOND; CHARCOAL; and GRAPHITE; and as SOOT from incompletely burned fuel.
The amount of radiation energy that is deposited in a unit mass of material, such as tissues of plants or animal. In RADIOTHERAPY, radiation dosage is expressed in gray units (Gy). In RADIOLOGIC HEALTH, the dosage is expressed by the product of absorbed dose (Gy) and quality factor (a function of linear energy transfer), and is called radiation dose equivalent in sievert units (Sv).
Stable elementary particles having the smallest known positive charge, found in the nuclei of all elements. The proton mass is less than that of a neutron. A proton is the nucleus of the light hydrogen atom, i.e., the hydrogen ion.
The total amount of radiation absorbed by tissues as a result of radiotherapy.
An atom or group of atoms that have a positive or negative electric charge due to a gain (negative charge) or loss (positive charge) of one or more electrons. Atoms with a positive charge are known as CATIONS; those with a negative charge are ANIONS.
The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability.
Isotopes that exhibit radioactivity and undergo radioactive decay. (From Grant & Hackh's Chemical Dictionary, 5th ed & McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
High-energy radiation or particles from extraterrestrial space that strike the earth, its atmosphere, or spacecraft and may create secondary radiation as a result of collisions with the atmosphere or spacecraft.
Tumors, cancer or other neoplasms produced by exposure to ionizing or non-ionizing radiation.
The ability of some cells or tissues to survive lethal doses of IONIZING RADIATION. Tolerance depends on the species, cell type, and physical and chemical variables, including RADIATION-PROTECTIVE AGENTS and RADIATION-SENSITIZING AGENTS.
A specialty field of radiology concerned with diagnostic, therapeutic, and investigative use of radioactive compounds in a pharmaceutical form.
The study of those aspects of energy and matter in terms of elementary principles and laws. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
Stable elementary particles having the smallest known negative charge, present in all elements; also called negatrons. Positively charged electrons are called positrons. The numbers, energies and arrangement of electrons around atomic nuclei determine the chemical identities of elements. Beams of electrons are called CATHODE RAYS.
A book is not a medical term, but generally refers to a set of printed or written sheets of paper bound together that can contain a wide range of information including literature, research, educational content, and more, which may be utilized in the medical field for various purposes such as learning, reference, or patient education.
Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures.

High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model. (1/246)

Recent studies suggest that radioimmunotherapy (RIT) with high-linear energy transfer (LET) radiation may have therapeutic advantages over conventional low-LET (e.g., beta-) emissions. Furthermore, fragments may be more effective in controlling tumor growth than complete IgG. However, to the best of our knowledge, no investigators have attempted a direct comparison of the therapeutic efficacy and toxicity of a systemic targeted therapeutic strategy, using high-LET alpha versus low-LET beta emitters in vivo. The aim of this study was, therefore, to assess the toxicity and antitumor efficacy of RIT with the alpha emitter 213Bi/213Po, as compared to the beta emitter 90Y, linked to a monovalent Fab' fragment in a human colonic cancer xenograft model in nude mice. Biodistribution studies of 213Bi- or 88Y-labeled benzyl-diethylene-triamine-pentaacetate-conjugated Fab' fragments of the murine monoclonal antibody CO17-1A were performed in nude mice bearing s.c. human colon cancer xenografts. 213Bi was readily obtained from an "in-house" 225Ac/213Bi generator. It decays by beta- and 440-keV gamma emission, with a t(1/2) of 45.6 min, as compared to the ultra-short-lived alpha emitter, 213Po (t(1/2) = 4.2 micros). For therapy, the mice were injected either with 213Bi- or 90Y-labeled CO17-1A Fab', whereas control groups were left untreated or were given a radiolabeled irrelevant control antibody. The maximum tolerated dose (MTD) of each agent was determined. The mice were treated with or without inhibition of the renal accretion of antibody fragments by D-lysine (T. M. Behr et al., Cancer Res., 55: 3825-3834, 1995), bone marrow transplantation, or combinations thereof. Myelotoxicity and potential second-organ toxicities, as well as tumor growth, were monitored at weekly intervals. Additionally, the therapeutic efficacy of both 213Bi- and 90Y-labeled CO17-1A Fab' was compared in a GW-39 model metastatic to the liver of nude mice. In accordance with kidney uptake values of as high as > or = 80% of the injected dose per gram, the kidney was the first dose-limiting organ using both 90Y- and 213Bi-labeled Fab' fragments. Application of D-lysine decreased the renal dose by >3-fold. Accordingly, myelotoxicity became dose limiting with both conjugates. By using lysine protection, the MTD of 90Y-Fab' was 250 microCi and the MTD of 213Bi-Fab' was 700 microCi, corresponding to blood doses of 5-8 Gy. Additional bone marrow transplantation allowed for an increase of the MTD of 90Y-Fab' to 400 microCi and for 213Bi-Fab' to 1100 microCi, respectively. At these very dose levels, no biochemical or histological evidence of renal damage was observed (kidney doses of <35 Gy). At equitoxic dosing, 213Bi-labeled Fab' fragments were significantly more effective than the respective 90Y-labeled conjugates. In the metastatic model, all untreated controls died from rapidly progressing hepatic metastases at 6-8 weeks after tumor inoculation, whereas a histologically confirmed cure was observed in 95% of those animals treated with 700 microCi of 213Bi-Fab' 10 days after model induction, which is in contrast to an only 20% cure rate in mice treated with 250 microCi of 90Y-Fab'. These data show that RIT with alpha emitters may be therapeutically more effective than conventional beta emitters. Surprisingly, maximum tolerated blood doses were, at 5-8 Gy, very similar between high-LET alpha and low-LET beta emitters. Due to its short physical half-life, 213Bi appears to be especially suitable for use in conjunction with fast-clearing fragments.  (+info)

Generalized concept of the LET-RBE relationship of radiation-induced chromosome aberration and cell death. (2/246)

The frequency of chromosome aberrations per traversal of a nucleus by a charged particle at the low dose limit increases proportionally to the square of the linear energy transfer (LET), peaks at about 100 keV/micron and then decreases with further increase of LET. This has long been interpreted as an excessive energy deposition over the necessary energy required to produce a biologically effective event. Here, we present an alternative interpretation. Cell traversed by a charged particle has certain probability to receive lethal damage leading to direct death. Such events may increase with an increase of LET and the number of charged particles traversing the cell. Assuming that the lethal damage is distributed according to a Poisson distribution, the probability that a cell has no such damage is expressed by e-cLx, where c is a constant, L is LET, and x is the number of charged particles traversing the cell. From these assumptions, the frequency of chromosome aberration in surviving cells can be described by Y = alpha SD + beta S2D2 with the empirical relation Y = alpha D + beta D2 in the low LET region, where S = e-cL, alpha is a value proportional to LET, beta is a constant, and D is the absorbed dose. This model readily explains the empirically established relationship between LET and relative biological effectiveness (RBE). The model can also be applied to clonogenic survival. If cells can survive and they have neither unstable chromosome aberrations nor other lethal damage, the LET-RBE relationship for clonogenic survival forms a humped curve. The relationship between LET and inactivation cross-section becomes proportional to the square of LET in the low LET region when the frequency of a directly lethal events is sufficiently smaller than unity, and the inactivation cross-section saturates to the cell nucleus cross-sectional area with an increase in LET in the high LET region.  (+info)

Mechanisms for the biological effectiveness of high-LET radiations. (3/246)

Radiations of high linear energy transfer (LET) have long been known to have greater biological effectiveness per unit dose than those of low LET, for a wide variety of biological effects. However, values of relative biological effectiveness depend considerably on the biological system and in some instances the values are clearly below unity. The differences between high- and low-LET radiations may be due to many factors, almost all of which are related to radiation track structure in one way or another, and some can in principle lead to qualitative as well as quantitative differences between the radiations. Explanations for LET-dependent differences in effectiveness are discussed over a variety of levels from the multicellular and cellular scale down to the DNA scale, with illustrations from radiobiological data. Information from well-defined slow light ions provide particularly useful analytic data, but practical issues extend also to neutrons and fast heavy ions, which may compound high- and low-LET features. It is suggested that effectiveness of the radiation is determined predominantly by the complex clustered damage that it produces in DNA, but that for high-LET radiations long-term effects are in some instances limited by single-track-survival probabilities of the traversed cells.  (+info)

Mutation induction and RBE of low energy neutrons in V79 cells. (4/246)

We have examined the neutron energy dependency of cell killing and mutation induction at the hprt locus in Chinese hamster V79 cells. Monoenergetic neutrons at 0.32, 0.57, and 1.2 MeV were generated at the Hiroshima University Radiobiological Research Accelerator (HIRRAC) Facility, and were used to irradiate cells. The variation in RBE with neutron energy for the end points of cell survival and hprt mutation induction was observed. When compared to 137Cs gamma-rays, all neutron energies were more effective at both cell killing and induction of mutation. Over the range of the neutron energies examined, we found that cytotoxicity increased as the energy decreased from 1.2 to 0.32 MeV. In comparison to gamma-rays, RBEs for cell lethality at 10% survival were 5.7, 6.7, and 7.6 for 1.2, 0.57, and 0.32 MeV, respectively. Mutation induction, on the other hand, was highest at 0.57 MeV with a gradual decrease at 1.2 and 0.32 MeV. RBEs for mutation induction were 9.7, 19.4, and 13.9 for 1.2, 0.57, and 0.32 MeV neutrons. We isolated independent V79 cell mutants at the hprt locus from untreated and neutron-exposed cells and determined the genetic changes underlying the mutation by multiplex polymerase chain reaction (PCR)-based exon deletion analysis. Preliminary results are suggestive of a specific relationship between deletion pattern and neutron energy.  (+info)

Neutron energy-dependent initial DNA damage and chromosomal exchange. (5/246)

This study was undertaken to investigate the biological effect of monoenergetic neutrons on human lymphocyte DNA and chromosomes. Monoenergetic neutrons of 2.3, 1.0, 0.79, 0.57, 0.37 and 0.186 MeV were generated, and 252Cf neutrons and 60Co gamma-rays were also used for comparison. Biological effect was evaluated two ways. The RBE values with the comet assay were estimated as 6.3 and 5.4 at 0.37 MeV and 0.57 MeV relative to that of 60Co gamma-rays, and chromosome aberration rates were also observed in these different levels of monoenergetic neutrons. The yield of chromosome aberrations per unit dose was high at lower neutron energies with a gradual decline with 0.186 MeV neutron energy. The RBE was increased to 10.7 at 0.57 MeV from 3.9 at 252Cf neutrons and reached 16.4 as the highest RBE at 0.37 MeV, but the value decreased to 11.2 at 0.186 MeV. The response patterns of initial DNA damage and chromosome exchange were quite similar to that of LET. These results show that the intensity of DNA damage and chromosomal exchange is LET dependent. RBE of low energy neutrons is higher than that of fission neutrons. Low energy neutrons containing Hiroshima atomic bomb radiation may have created a significantly higher incidence of biological effect in atomic bomb survivors.  (+info)

Neutron-energy-dependent cell survival and oncogenic transformation. (6/246)

Both cell lethality and neoplastic transformation were assessed for C3H10T1/2 cells exposed to neutrons with energies from 0.040 to 13.7 MeV. Monoenergetic neutrons with energies from 0.23 to 13.7 MeV and two neutron energy spectra with average energies of 0.040 and 0.070 MeV were produced with a Van de Graaff accelerator at the Radiological Research Accelerator Facility (RARAF) in the Center for Radiological Research of Columbia University. For determination of relative biological effectiveness (RBE), cells were exposed to 250 kVp X rays. With exposures to 250 kVp X rays, both cell survival and radiation-induced oncogenic transformation were curvilinear. Irradiation of cells with neutrons at all energies resulted in linear responses as a function of dose for both biological endpoints. Results indicate a complex relationship between RBEm and neutron energy. For both survival and transformation, RBEm was greatest for cells exposed to 0.35 MeV neutrons. RBEm was significantly less at energies above or below 0.35 MeV. These results are consistent with microdosimetric expectation. These results are also compatible with current assessments of neutron radiation weighting factors for radiation protection purposes. Based on calculations of dose-averaged LET, 0.35 MeV neutrons have the greatest LET and therefore would be expected to be more biologically effective than neutrons of greater or lesser energies.  (+info)

RBE-LET relationships in mutagenesis by ionizing radiation. (7/246)

The paper considers the relationship between the quality of radiation and biological lesions produced by ionizing radiation. The paper provides a brief review of the modelling of induction of strand breakage, chromosome aberration, revertant mutation in bacteria and Drosophila melanogaster. Experimental data are presented for the relative biological effectiveness of helium ions and alpha-particles for mutation induction and genome lethality in Escherichia coli. The paper examines the relationship between the mutational events and LET. The RBE-LET values for T4 phage, E. coli WP2 and mwh (multiple wing hair) show dependency on LET while the wi (white-ivory) allele mutants show no dependency.  (+info)

RBE-LET relationships of high-LET radiations in Drosophila mutations. (8/246)

The relative biological effectiveness (RBE) of 252Cf neutrons and synchrotron-generated high-energy charged particles for mutation induction was evaluated as a function of linear energy transfer (LET), using the loss of heterozygosity for wing-hair mutations and the reversion of the mutant white-ivory eye-color in Drosophila melanogaster. Loss of heterozygosity for wing-hair mutations results predominantly from mitotic crossing over induced in wing anlage cells of larvae, while the reverse mutation of eye-color is due to an intragenic structural change (2.96 kb-DNA excision) in the white locus on the X-chromosome. The measurements were performed in a combined mutation assay system so that induced mutant wing-hair clones as well as revertant eye-color clone can be detected simultaneously in the same individual. Larvae were irradiated at the age of 3 days post oviposition with 252Cf neutrons, carbon beam or neon beam. For the neutron irradiation, the RBE values for wing-hair mutations were larger than that for eye-color mutation by about 7 fold. The RBE of carbon ions for producing the wing-hair mutations increased with increase in LET. The estimated RBE values were found to be in the range 2 to 6.5 for the wing-hair. For neon beam irradiation, the RBE values for wing-hair mutations peak near 150 keV/micron and decrease with further increase in LET. On the other hand, the RBE values for the induction of the eye-color mutation are nearly unity in 252Cf neutrons and both ions throughout the LET range irradiated. We discuss the relationships between the initial DNA damage and LET in considering the mechanism of somatic mutation induction.  (+info)

Relative Biological Effectiveness (RBE) is a term used in radiation biology and medicine to describe the relative effectiveness of different types or energies of ionizing radiation in causing biological damage, compared to a reference radiation such as high-energy photons (X-rays or gamma rays). RBE takes into account the differences in biological impact between various types of radiation, which can be due to differences in linear energy transfer (LET), quality factor, and other factors. It is used to estimate the biological effects of mixed radiation fields, such as those encountered in radiotherapy treatments that combine different types or energies of radiation. The RBE value for a specific type of radiation is determined through experimental studies that compare its biological impact to that of the reference radiation.

Linear Energy Transfer (LET) is a concept in radiation physics that describes the amount of energy that is transferred from an ionizing particle to a medium per unit length along its path. It is usually expressed in units of keV/μm (kiloelectron volts per micrometer). High-LET radiations, such as alpha particles and heavy ions, transfer more energy to the medium per unit length than low-LET radiations, such as X-rays and gamma rays. This results in a higher probability of producing dense ionizations and causing biological damage along the particle's path. Therefore, LET is an important factor in determining the relative biological effectiveness (RBE) of different types of radiation.

Heavy ions, in the context of medicine, typically refer to charged particles that are used in the field of radiation therapy for cancer treatment. These particles are much heavier than electrons and carry a positive charge, unlike the negatively charged electrons or neutral photons used in conventional radiotherapy.

The term "heavy ions" is often associated with carbon ions or other ions like oxygen or neon. The high mass and charge of these particles result in unique physical properties that allow for more targeted and precise cancer treatment compared to traditional radiation therapy methods.

When heavy ions pass through tissue, they deposit most of their energy at the end of their range, creating a narrow, highly-damaging track known as the Bragg peak. This property enables clinicians to concentrate the dose of radiation within the tumor while minimizing exposure to surrounding healthy tissues. The result is a potentially more effective and less toxic treatment option for certain types of cancer, particularly those that are radioresistant or located near critical organs.

It's important to note that heavy ion therapy requires specialized equipment, such as particle accelerators and gantry systems, which limits its availability to a smaller number of medical facilities worldwide.

Californium is a synthetic actinide radioactive metallic element with the symbol Cf and atomic number 98. It was first synthesized in 1950 by Stanley G. Thompson, Kenneth Street, Jr., Albert Ghiorso, and Glenn T. Seaborg at the University of California, Berkeley. Californium is produced artificially in nuclear reactors and does not occur naturally.

Californium has several isotopes, with the most stable being californium-251, which has a half-life of 898 years. It is used in various applications, including as a power source for artificial heart pacemakers, as a neutron source for industrial radiography, and in cancer treatment.

It's important to note that due to its radioactive nature, californium must be handled with great care and precaution, and its use is regulated by governmental agencies such as the Nuclear Regulatory Commission in the United States.

"Fast neutrons" are defined in the field of medical physics and nuclear medicine as neutrons that have high kinetic energy, typically greater than 1 MeV (mega-electron volts). These high-energy neutrons can cause ionization and damage to tissues and cells when they interact with matter, including biological tissue. They are produced in various nuclear reactions, such as those occurring in the core of a nuclear reactor or in the detonation of a nuclear weapon. In medical contexts, fast neutrons may be used in radiation therapy for cancer treatment, where they can deposit their energy directly into tumors and cause DNA damage that leads to cell death.

Cobalt radioisotopes are radioactive forms of the element cobalt, which are used in various medical applications. The most commonly used cobalt radioisotope is Cobalt-60 (Co-60), which has a half-life of 5.27 years.

Co-60 emits gamma rays and beta particles, making it useful for radiation therapy to treat cancer, as well as for sterilizing medical equipment and food irradiation. In radiation therapy, Co-60 is used in teletherapy machines to deliver a focused beam of radiation to tumors, helping to destroy cancer cells while minimizing damage to surrounding healthy tissue.

It's important to note that handling and disposal of cobalt radioisotopes require strict safety measures due to their radioactive nature, as they can pose risks to human health and the environment if not managed properly.

Heavy Ion Radiotherapy is a type of external beam radiation therapy used in the treatment of cancer. It uses beams of heavy, charged particles such as carbon or lead ions to deliver high doses of radiation directly to tumor cells while minimizing exposure and damage to surrounding healthy tissues. This is achieved by taking advantage of the unique physical properties of these particles, which can deposit their energy more densely in tissue and stop closer to the tumor site compared to conventional photon or electron beams.

The process involves accelerating the heavy ions to near-light speeds using a particle accelerator, then directing them at the tumor with precision. Upon interaction with the tumor cells, these high-energy particles cause ionization and DNA damage, leading to cell death and shrinkage or eradication of the tumor. Heavy Ion Radiotherapy has been shown to be effective in treating certain types of cancer, including some radioresistant tumors, due to its increased biological effectiveness compared to conventional radiotherapy techniques.

A dose-response relationship in radiation refers to the correlation between the amount of radiation exposure (dose) and the biological response or adverse health effects observed in exposed individuals. As the level of radiation dose increases, the severity and frequency of the adverse health effects also tend to increase. This relationship is crucial in understanding the risks associated with various levels of radiation exposure and helps inform radiation protection standards and guidelines.

The effects of ionizing radiation can be categorized into two types: deterministic and stochastic. Deterministic effects have a threshold dose below which no effect is observed, and above this threshold, the severity of the effect increases with higher doses. Examples include radiation-induced cataracts or radiation dermatitis. Stochastic effects, on the other hand, do not have a clear threshold and are based on probability; as the dose increases, so does the likelihood of the adverse health effect occurring, such as an increased risk of cancer.

Understanding the dose-response relationship in radiation exposure is essential for setting limits on occupational and public exposure to ionizing radiation, optimizing radiation protection practices, and developing effective medical countermeasures in case of radiation emergencies.

Radiobiology is the scientific study of the effects of ionizing radiation on living organisms, including both normal tissue and tumors. It encompasses the investigation of the biological responses to various types and doses of radiation, as well as the mechanisms behind these reactions at molecular, cellular, tissue, and systemic levels. The knowledge gained from radiobiology is crucial for optimizing radiation therapy in cancer treatment, setting radiation safety standards, and understanding the biological consequences of radiation exposure in diagnostic and occupational settings.

Alpha particles are a type of radiation that consist of two protons and two neutrons. They are essentially the nuclei of helium atoms and are produced during the decay of radioactive isotopes, such as uranium or radon. When an alpha particle is emitted from a radioactive atom, it carries away energy and causes the atom to transform into a different element with a lower atomic number and mass number.

Alpha particles have a positive charge and are relatively massive compared to other types of radiation, such as beta particles (which are high-energy electrons) or gamma rays (which are high-energy photons). Because of their charge and mass, alpha particles can cause significant ionization and damage to biological tissue. However, they have a limited range in air and cannot penetrate the outer layers of human skin, making them generally less hazardous than other forms of radiation if exposure is external.

Internal exposure to alpha-emitting radionuclides, however, can be much more dangerous because alpha particles can cause significant damage to cells and DNA when they are emitted inside the body. This is why inhaling or ingesting radioactive materials that emit alpha particles can pose a serious health risk.

Astatine is a naturally occurring, radioactive, semi-metallic chemical element with the symbol At and atomic number 85. It is the rarest naturally occurring element in the Earth's crust, and the heaviest of the halogens. Astatine is not found free in nature, but is always found in combination with other elements, such as uranium and thorium.

Astatine is a highly reactive element that exists in several allotropic forms and is characterized by its metallic appearance and chemical properties similar to those of iodine. It has a short half-life, ranging from a few hours to a few days, depending on the isotope, and emits alpha, beta, and gamma radiation.

Due to its rarity, radioactivity, and short half-life, astatine has limited practical applications. However, it has been studied for potential use in medical imaging and cancer therapy due to its ability to selectively accumulate in tumors.

I'm sorry for any confusion, but neutrons are not a medical term. They are a fundamental particle in physics and chemistry. Neutrons are neutral particles found in the nucleus of an atom, alongside protons. Together, they make up the atomic nucleus, while electrons orbit around it.

Neutrons are not typically discussed in the context of medical definitions unless it's in relation to nuclear medicine, radiation therapy or other specialized medical fields that involve ionizing radiation and nuclear reactions. If you have any questions related to medical terminology, I would be happy to help!

I'm sorry for any confusion, but "Particle Accelerators" are not a medical term. Particle accelerators are large pieces of scientific equipment that use electromagnetic fields to propel charged particles to high speeds and contain them in well-defined beams. They are used for a variety of purposes, including research in particle physics, nuclear physics, and synchrotron light sources in a wide range of disciplines, such as condensed matter physics, chemistry, biology, and materials science. If you have any questions about medical terminology or concepts, I would be happy to help with those!

I'm sorry for any confusion, but "nuclear fission" is not a term typically used in medical definitions. It is a concept from nuclear physics. Nuclear fission is the process of splitting a heavy, unstable atomic nucleus (such as uranium-235 or plutonium-239) into two lighter nuclei, along with a few subatomic particles (like neutrons and photons) and a large release of energy. This process can occur naturally, but it is also used in nuclear power plants and atomic bombs.

Gamma rays are a type of ionizing radiation that is released from the nucleus of an atom during radioactive decay. They are high-energy photons, with wavelengths shorter than 0.01 nanometers and frequencies greater than 3 x 10^19 Hz. Gamma rays are electromagnetic radiation, similar to X-rays, but with higher energy levels and the ability to penetrate matter more deeply. They can cause damage to living tissue and are used in medical imaging and cancer treatment.

Radiometry is the measurement of electromagnetic radiation, including visible light. It quantifies the amount and characteristics of radiant energy in terms of power or intensity, wavelength, direction, and polarization. In medical physics, radiometry is often used to measure therapeutic and diagnostic radiation beams used in various imaging techniques and cancer treatments such as X-rays, gamma rays, and ultraviolet or infrared light. Radiometric measurements are essential for ensuring the safe and effective use of these medical technologies.

X-rays, also known as radiographs, are a type of electromagnetic radiation with higher energy and shorter wavelength than visible light. In medical imaging, X-rays are used to produce images of the body's internal structures, such as bones and organs, by passing the X-rays through the body and capturing the resulting shadows or patterns on a specialized film or digital detector.

The amount of X-ray radiation used is carefully controlled to minimize exposure and ensure patient safety. Different parts of the body absorb X-rays at different rates, allowing for contrast between soft tissues and denser structures like bone. This property makes X-rays an essential tool in diagnosing and monitoring a wide range of medical conditions, including fractures, tumors, infections, and foreign objects within the body.

In the context of medical definitions, 'carbon' is not typically used as a standalone term. Carbon is an element with the symbol C and atomic number 6, which is naturally abundant in the human body and the environment. It is a crucial component of all living organisms, forming the basis of organic compounds, such as proteins, carbohydrates, lipids, and nucleic acids (DNA and RNA).

Carbon forms strong covalent bonds with various elements, allowing for the creation of complex molecules that are essential to life. In this sense, carbon is a fundamental building block of life on Earth. However, it does not have a specific medical definition as an isolated term.

Radiation dosage, in the context of medical physics, refers to the amount of radiation energy that is absorbed by a material or tissue, usually measured in units of Gray (Gy), where 1 Gy equals an absorption of 1 Joule of radiation energy per kilogram of matter. In the clinical setting, radiation dosage is used to plan and assess the amount of radiation delivered to a patient during treatments such as radiotherapy. It's important to note that the biological impact of radiation also depends on other factors, including the type and energy level of the radiation, as well as the sensitivity of the irradiated tissues or organs.

In the context of medicine, particularly in relation to cancer treatment, protons refer to positively charged subatomic particles found in the nucleus of an atom. Proton therapy, a type of radiation therapy, uses a beam of protons to target and destroy cancer cells with high precision, minimizing damage to surrounding healthy tissue. The concentrated dose of radiation is delivered directly to the tumor site, reducing side effects and improving quality of life during treatment.

Radiotherapy dosage refers to the total amount of radiation energy that is absorbed by tissues or organs, typically measured in units of Gray (Gy), during a course of radiotherapy treatment. It is the product of the dose rate (the amount of radiation delivered per unit time) and the duration of treatment. The prescribed dosage for cancer treatments can range from a few Gray to more than 70 Gy, depending on the type and location of the tumor, the patient's overall health, and other factors. The goal of radiotherapy is to deliver a sufficient dosage to destroy the cancer cells while minimizing damage to surrounding healthy tissues.

An ion is an atom or molecule that has gained or lost one or more electrons, resulting in a net electric charge. Cations are positively charged ions, which have lost electrons, while anions are negatively charged ions, which have gained electrons. Ions can play a significant role in various physiological processes within the human body, including enzyme function, nerve impulse transmission, and maintenance of acid-base balance. They also contribute to the formation of salts and buffer systems that help regulate fluid composition and pH levels in different bodily fluids.

Cell survival refers to the ability of a cell to continue living and functioning normally, despite being exposed to potentially harmful conditions or treatments. This can include exposure to toxins, radiation, chemotherapeutic drugs, or other stressors that can damage cells or interfere with their normal processes.

In scientific research, measures of cell survival are often used to evaluate the effectiveness of various therapies or treatments. For example, researchers may expose cells to a particular drug or treatment and then measure the percentage of cells that survive to assess its potential therapeutic value. Similarly, in toxicology studies, measures of cell survival can help to determine the safety of various chemicals or substances.

It's important to note that cell survival is not the same as cell proliferation, which refers to the ability of cells to divide and multiply. While some treatments may promote cell survival, they may also inhibit cell proliferation, making them useful for treating diseases such as cancer. Conversely, other treatments may be designed to specifically target and kill cancer cells, even if it means sacrificing some healthy cells in the process.

Radioisotopes, also known as radioactive isotopes or radionuclides, are variants of chemical elements that have unstable nuclei and emit radiation in the form of alpha particles, beta particles, gamma rays, or conversion electrons. These isotopes are formed when an element's nucleus undergoes natural or artificial radioactive decay.

Radioisotopes can be produced through various processes, including nuclear fission, nuclear fusion, and particle bombardment in a cyclotron or other types of particle accelerators. They have a wide range of applications in medicine, industry, agriculture, research, and energy production. In the medical field, radioisotopes are used for diagnostic imaging, radiation therapy, and in the labeling of molecules for research purposes.

It is important to note that handling and using radioisotopes requires proper training, safety measures, and regulatory compliance due to their ionizing radiation properties, which can pose potential health risks if not handled correctly.

Cosmic radiation refers to high-energy radiation that originates from space. It is primarily made up of charged particles, such as protons and electrons, and consists of several components including galactic cosmic rays, solar energetic particles, and trapped radiation in Earth's magnetic field (the Van Allen belts).

Galactic cosmic rays are high-energy particles that originate from outside our solar system. They consist mainly of protons, with smaller amounts of helium nuclei (alpha particles) and heavier ions. These particles travel at close to the speed of light and can penetrate the Earth's atmosphere, creating a cascade of secondary particles called "cosmic rays" that can be measured at the Earth's surface.

Solar energetic particles are high-energy charged particles, mainly protons and alpha particles, that are released during solar flares or coronal mass ejections (CMEs) from the Sun. These events can accelerate particles to extremely high energies, which can pose a radiation hazard for astronauts in space and for electronic systems in satellites.

Trapped radiation in Earth's magnetic field is composed of charged particles that are trapped by the Earth's magnetic field and form two doughnut-shaped regions around the Earth called the Van Allen belts. The inner belt primarily contains high-energy electrons, while the outer belt contains both protons and electrons. These particles can pose a radiation hazard for satellites in low Earth orbit (LEO) and for astronauts during spacewalks or missions beyond LEO.

Cosmic radiation is an important consideration for human space exploration, as it can cause damage to living tissue and electronic systems. Therefore, understanding the sources, properties, and effects of cosmic radiation is crucial for ensuring the safety and success of future space missions.

Radiation-induced neoplasms are a type of cancer or tumor that develops as a result of exposure to ionizing radiation. Ionizing radiation is radiation with enough energy to remove tightly bound electrons from atoms or molecules, leading to the formation of ions. This type of radiation can damage DNA and other cellular structures, which can lead to mutations and uncontrolled cell growth, resulting in the development of a neoplasm.

Radiation-induced neoplasms can occur after exposure to high levels of ionizing radiation, such as that received during radiation therapy for cancer treatment or from nuclear accidents. The risk of developing a radiation-induced neoplasm depends on several factors, including the dose and duration of radiation exposure, the type of radiation, and the individual's genetic susceptibility to radiation-induced damage.

Radiation-induced neoplasms can take many years to develop after initial exposure to ionizing radiation, and they often occur at the site of previous radiation therapy. Common types of radiation-induced neoplasms include sarcomas, carcinomas, and thyroid cancer. It is important to note that while ionizing radiation can increase the risk of developing cancer, the overall risk is still relatively low, especially when compared to other well-established cancer risk factors such as smoking and exposure to certain chemicals.

Radiation tolerance, in the context of medicine and particularly radiation oncology, refers to the ability of tissues or organs to withstand and recover from exposure to ionizing radiation without experiencing significant damage or loss of function. It is often used to describe the maximum dose of radiation that can be safely delivered to a specific area of the body during radiotherapy treatments.

Radiation tolerance varies depending on the type and location of the tissue or organ. For example, some tissues such as the brain, spinal cord, and lungs have lower radiation tolerance than others like the skin or bone. Factors that can affect radiation tolerance include the total dose of radiation, the fractionation schedule (the number and size of radiation doses), the volume of tissue treated, and the individual patient's overall health and genetic factors.

Assessing radiation tolerance is critical in designing safe and effective radiotherapy plans for cancer patients, as excessive radiation exposure can lead to serious side effects such as radiation-induced injury, fibrosis, or even secondary malignancies.

Nuclear medicine is a branch of medical imaging that uses small amounts of radioactive material, called radiopharmaceuticals, to diagnose and treat various diseases. The radiopharmaceuticals are taken internally, usually through injection or oral administration, and accumulate in specific organs or tissues. A special camera then detects the radiation emitted by these substances, which helps create detailed images of the body's internal structures and functions.

The images produced in nuclear medicine can help doctors identify abnormalities such as tumors, fractures, infection, or inflammation. Additionally, some radiopharmaceuticals can be used to treat certain conditions, like hyperthyroidism or cancer, by delivering targeted doses of radiation directly to the affected area. Overall, nuclear medicine provides valuable information for the diagnosis, treatment planning, and monitoring of many medical conditions.

I'm sorry for any confusion, but "physics" is not a term that has a medical definition. Physics is a branch of science that deals with the study of matter, energy, and their interactions. It may be studied in the context of medical physics, which involves the application of physical principles to medicine, such as in the use of radiation therapy for cancer treatment or imaging techniques like MRI and CT scans. However, "physics" itself is not a medical term with a specific definition within the field of medicine.

An electron is a subatomic particle, symbol e-, with a negative electric charge. Electrons are fundamental components of atoms and are responsible for the chemical bonding between atoms to form molecules. They are located in an atom's electron cloud, which is the outermost region of an atom and contains negatively charged electrons that surround the positively charged nucleus.

Electrons have a mass that is much smaller than that of protons or neutrons, making them virtually weightless on the atomic scale. They are also known to exhibit both particle-like and wave-like properties, which is a fundamental concept in quantum mechanics. Electrons play a crucial role in various physical phenomena, such as electricity, magnetism, and chemical reactions.

I apologize for any confusion, but "books" is a general term that refers to bound sets of pages that are printed or written with text, illustrations, or signs, and are meant to be read, studied, or consulted. It does not have a specific medical definition. If you're looking for information about a specific medical term or concept, please let me know and I'd be happy to help!

Molecular models are three-dimensional representations of molecular structures that are used in the field of molecular biology and chemistry to visualize and understand the spatial arrangement of atoms and bonds within a molecule. These models can be physical or computer-generated and allow researchers to study the shape, size, and behavior of molecules, which is crucial for understanding their function and interactions with other molecules.

Physical molecular models are often made up of balls (representing atoms) connected by rods or sticks (representing bonds). These models can be constructed manually using materials such as plastic or wooden balls and rods, or they can be created using 3D printing technology.

Computer-generated molecular models, on the other hand, are created using specialized software that allows researchers to visualize and manipulate molecular structures in three dimensions. These models can be used to simulate molecular interactions, predict molecular behavior, and design new drugs or chemicals with specific properties. Overall, molecular models play a critical role in advancing our understanding of molecular structures and their functions.

No FAQ available that match "relative biological effectiveness"

No images available that match "relative biological effectiveness"